With us is Lou Tharp, Co-Founder and Executive Director at GHLF
(PubMed) Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M
MDM2 , forward: GAATCATCGGACTCAGGTACATC, reverse: TCTGTCTCACTAATTGCTCTCCT
Currently approved delivery methods include: Subcutaneous injection : The most common route, using pre-filled pens for once-weekly (semaglutide, dulaglutide) or once-daily (liraglutide) administration Oral tablets : Semaglutide (Rybelsus) is the only FDA-approved oral GLP-1 medication, utilizing absorption-enhancing technology No transdermal patch formulation has received FDA approval for GLP-1 delivery
According to different types of prostate cancer, there are four key treatment methods: radical prostatectomy, chemotherapy, androgen deprivation and radiotherapy [5]